Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Cardiovascular Conditions and Diseases
      • Digital Health
      • Health Policy
      • Immunity and Infectious Diseases
      • Joint Health and Mobility
      • Respiratory and Lung Health
      • Spinal Cord Injury and Rehabilitation
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • Ovarian Cancer Research Centre
      • Vancouver Prostate Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • CST Cerner at VCH
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Education and Training
      • Communications and Branding
      • Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Innovation and Partnership
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Participate in Research
  3. Men's and Women's Health

Men's and Women's Health

Participate in Men's and Women's Health studies at VCHRI.

Recruiting

Exploring virtual reality for fear of vaginal penetration

The purpose of this study is to explore virtual reality (VR) exposure for the treatment of vaginismus, also known as fear of painful vaginal penetration. Vaginismus is common and affected individuals experience difficulties with vaginal intercourse and gynaecological exams. Available treatments are not very effective. Cognitive behavioural therapy with an exposure element (insertion of vaginal dilators in the presence of a clinician) is highly effective, but unavailable in Canada.

Status
Recruiting
Principal Investigator
Lori Brotto
Body Locations and Systems
Men's and Women's Health
Sexual Health
Age
19 and above

Perimenopause Brain Health

The purpose of this study is to is to examine the effects of 12 weeks of high intensity interval training on the cognitive health of perimenopausal woman.

Status
Recruiting
Principal Investigator
Teresa Liu-Ambrose
Body Locations and Systems
Brain
Women's Health
Area
Vancouver
Age
45-55

Online study: Diversity of sexual preferences

We would like to explore different aspects of sexual identity among individuals who self-identify as asexual, bisexual, gay or heterosexual.

Recruitment Poster

Status
Recruiting
Principal Investigator
Lori Brotto
Body Locations and Systems
Men's and Women's Health
Sexual Health
Area
Vancouver
Age
19-45 years

Prostate cancer support from a peer

TrueNTH (True North) Peer Navigation is a new study that puts trained prostate cancer survivors and caregivers in touch with patients and caregivers looking for support. Peer navigators will help prostate cancer patients and caregivers navigate their journey through cancer care, from the point of diagnosis to treatment and beyond and will provide emotional, practical, and informational support. This work was awarded by Prostate Cancer Canada and is proudly funded by the Movember Foundation.

Status
Recruiting
Principal Investigator
Arminee Kazanjian
Body Locations and Systems
Prostate Cancer
Area
Vancouver
Age
19 and above

Feasibility of using the ARES Device to measure sleep in men with prostate cancer starting androgen deprivation therapy

The primary purpose of our study is to examine the feasibility of using the ARESTM device to measure sleep parameters of PCa patients who are on ADT. In addition, we will also assess the feasibility of obtaining serial questionnaires from patients. In this small pilot study, we will describe subjective sleep quality, morphometric measures, urinary symptoms, hot flashes, and weight gain.

Recruitment Poster

Status
Recruiting
Principal Investigator
Larry Goldenberg
Body Locations and Systems
Prostate Cancer
Area
Vancouver

Birth, childhood health and psychosis outcomes

The goal of the current study is to determine the prevalence, rate, and types of pregnancy complications and early life events that may be associated with the emergence of psychosis and related metabolic disorder in patients with schizophrenia spectrum disorders.

Recruitment Poster

Status
Recruiting
Principal Investigator
Donna Jane M Lang
Body Locations and Systems
Men's and Women's Health
Area
Vancouver
Age
16-45

Women's Heart Attack Research Program- Imaging Study (HARP)

The Women's HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in women with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every 6 months, for a maximum of 3 years.

Status
Recruiting
Principal Investigator
Tara Sedlak
Body Locations and Systems
Heart Attack
Heart Disease in Women
Area
Vancouver
Age
21-99

PC 360 Survivorship

Prostate Cancer Survivorship 360º is a collaboration-based initiative involving prostate cancer (PC) and survivorship researchers/clinicians from three Canadian prostate centers with the goal of identifying and tracking unmet supportive care needs of patients with localized PC and responding to these needs through survivorship care. The current randomized control trail (RCT) will focus on the development and evaluation of a facilitated electronic Prostate Cancer Survivorship Care Plan (PC-SCP).

Status
Recruiting
Principal Investigator
Larry Goldenberg
Body Locations and Systems
Prostate Cancer
Area
Vancouver
Age
18 and above

Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer (LS2)

This study will maximize identification of women with Lynch Syndrome using an enhanced screening strategy to identify those at risk. These women will be referred to genetic counselling for testing and those found to have Lynch Syndrome will be asked to invite first degree relatives to participate and undergo genetic testing for Lynch Syndrome.

Status
Recruiting
Principal Investigator
Janice Kwon
Body Locations and Systems
Ovarian Disorders
Area
Vancouver
Age
18-70

Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients (ELICE_BD)

This is a randomized, double-blind, placebo-controlled, multicentre, parallel-group study to assess the cognitive effects of lurasidone in bipolar I and II patients (manic depression) who are in remission from an episode. Participants who show cognitive impairment at the screening visit will be enrolled into the study and randomized at the baseline visit to receive either lurasidone or placebo adjunctive therapy in a 1:1 ratio for 6 weeks.

Recruitment Poster

Status
Recruiting
Principal Investigator
Lakshmi Yatham
Body Locations and Systems
Bipolar Disorder
Men's and Women's Health
Area
Vancouver
Age
19-65

Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer (proSPECT-AS)

99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic Gleason grade of ≤ 3+4 severity and / or are candidates for active surveillance, but have planned to undergo radical prostatectomy. In these patients, the results may be used to help estimate the risk of a histopathologic Gleason grade of > 3+4. This Phase 3 study is designed to evaluate the specificity and sensitivity of 99mTc-MIP-1404 to detect clinically significant prostate cancer when compared to histopathology.

Status
Recruiting
Principal Investigator
Philip Cohen
Body Locations and Systems
Prostate Cancer
Area
Various sites
Age
18 and above

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

Status
Recruiting
Principal Investigator
Martin Gleave
Body Locations and Systems
Prostate Cancer
Area
Vancouver
Age
18 and above

A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC (TITAN)

The purpose of this study is to determine if the addition of JNJ-56021927 to ADT provides superior efficacy in improving radiographic progression-free survival (rPFS) or overall survival (OS) for participants with low volume mHSPC.

Status
Recruiting
Principal Investigator
Kim Nguyen Chi
Body Locations and Systems
Prostate Cancer
Area
Vancouver
Age
18 and above

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

The goal of this clinical research study is to learn if treatment with standard systemic therapy in combination with surgery or radiation therapy is more effective at controlling prostate cancer than standard systemic therapy alone. The safety of this treatment combination will also be studied.

Status
Recruiting
Principal Investigator
Martin Gleave
Body Locations and Systems
Prostate Cancer
Area
Vancouver
Age
18 and above

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer (PROSPER)

The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.

Status
Recruiting
Principal Investigator
Martin Gleave
Body Locations and Systems
Prostate Cancer
Area
Vancouver
Age
18 and above

Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer (EMMPC)

The investigators aim to evaluate the feasibility of a larger clinical trial assessing an exercise program during the "teachable moment" in patients with prostate cancer and measuring its effect on tumor apoptosis signaling, lipogenesis and steroidogenesis. Participants will be randomized between a 8-12 week exercise program or to standard of care only. Participants will be assessed at screening, baseline (day 0), throughout the trial intervention (days 1-84), post-intervention visit (prior to radical prostatectomy) and final study visit 6-months post-radical prostatectomy.

Status
Recruiting
Principal Investigator
Peter Black
Body Locations and Systems
Prostate Cancer
Area
Vancouver
Age
19 and above

Falls Prevention Clinic

At the Falls Prevention Clinic, each subject receives a comprehensive assessment of his or her individual risk factors for falling in addition to a comprehensive medical examination. Recommendations and appropriate follow up tests and referrals are ordered for patients on an individual basis.

Status
Recruiting
Principal Investigator
Teresa Liu-Ambrose
Body Locations and Systems
Fractures
Men's and Women's Health
Area
Various sites
Age
70 and above

Etiology Study of Prostatitis

Prostatitis is so widespread a disease that affects people from youths to seniors, with approximately a third experiencing a remission of symptoms over a year follow-up. Although the etiology of prostatitis is still not clear, it is mainly thought to be due to infection of bacteria or other microorganisms. Up to now, there is still no research being done on the microbiome (bacterial species) of the prostate. The objective of this study is to look at the etiology of chronic prostatitis (bacteria or non-bacteria prostatitis), mainly focusing on the effect of bacteria in the prostate.

Status
Recruiting
Principal Investigator
Ben Chew
Body Locations and Systems
Prostate Diseases
Area
Vancouver
Age
19 and above

Closed for Recruitment

Cognitive-Behavioural and Mindfulness-Based Online Programs for Female Sexual Dysfunction

The purpose of this study is to evaluate two online psychological programs that address sexual concerns in women. Both programs have been found to be effective for sexual concerns when administered in face-to-face programs. However, many women lack access to these face-to-face interventions, which leaves them unable to access the care they need. These treatments have been adapted to online delivery in a program called eSense, and the eventual goal is to make these helpful treatments more accessible.

Status
Closed for Recruitment
Principal Investigator
Lori Brotto
Body Locations and Systems
Men's and Women's Health
Sexual Health
Age
19 and above

COVID Elicited Responses to Sexual Health

The purpose of this study is to understand the short- and long-term impacts of COVID-19 on social, psychological and behavioural aspects of sexual health. 

Status
Closed for Recruitment
Principal Investigator
Lori Brotto
Body Locations and Systems
Men's and Women's Health
Sexual Health
Area
Vancouver
Age
19 and above

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page
Subscribe to Men's and Women's Health

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • Twitter
  • LinkedIn

© 2023 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy